Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells

Published:2008-01 Issue:1 Volume:19 Page:55-64
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Chen Yu-Jen,Kuo Cheng-Deng,Tsai Yin-Meng,Yu Chih-Chia,Wang Guang-Sheng,Liao Hui-Fen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference33 articles.

1. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode;Baba;Bioorg Med Chem,2005

2. Medical uses of mylabris in ancient China and recent studies;Wang;J Ethnopharmacol,1989

3. An investigation on liver: targeting microemulsions of norcantharidin;Zhang;Drug Deliv,2005

4. In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin;Massicot;Basic Clin Pharmacol Toxicol,2005

5. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes;Kok;Oral Oncol,2003

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Qizhu Anti-Cancer Recipe promotes anoikis of hepatocellular carcinoma cells by activating the c-Jun N-terminal kinase pathway;Heliyon;2023-11

2. DFT Treatment of Some Cantharidine Isomers and Some Radicals from Them;Earthline Journal of Chemical Sciences;2023-03-21

3. Mitochondria dysfunction in circulating tumor cells;Frontiers in Oncology;2022-08-04

4. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities;Chinese Medicine;2020-05-29

5. NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling;Molecular Medicine Reports;2020-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3